新闻来源：www.bloomberg.com
原文地址：AstraZeneca Defends China Compliance In Wake of Staff Detentions
新闻日期：2024-09-10
阿斯特拉Zeneca首席执行官索里奥表示，公司在中国正与当局保持紧密合作，并且有强健的合规政策。中国政府对阿斯特拉的调查涉及八九名员工，索里奥在接受Bloomberg TV采访时说，公司在华员工总数为12,000人。索里奥还指出，要求每个员工都充当合规官员“不可能”。
原文摘要：
Drugmaker cooperating with authorities in probe, CEO says. Company faces headwinds including mixed cancer trial results. AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees in the country, Chief Executive Officer Pascal Soriot said.. A Chinese government probe into Astra centers on eight or nine employees, Soriot said in a Bloomberg TV interview, noting that the firm employs 12,000 people in the country. It’s “impossible” for every employee to act as a compliance officer, the CEO said..
